ANGO vs SPGI · rev $292.5M vs P/E 27, rev $15.34B
AngioDynamics Inc (ANGO) versus S&P Global Inc (SPGI) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
ANGO currently screens at market cap $378.5M. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Not investment advice. Open the ANGO and SPGI stock pages for the full models.
Not investment advice.